These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9915308)

  • 1. A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide.
    Wright PM; Brown R; Lau M; Fisher DM
    Anesthesiology; 1999 Jan; 90(1):16-23. PubMed ID: 9915308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic modeling of vecuronium-induced twitch depression. Rapid plasma-effect site equilibration explains faster onset at resistant laryngeal muscles than at the adductor pollicis.
    Fisher DM; Szenohradszky J; Wright PM; Lau M; Brown R; Sharma M
    Anesthesiology; 1997 Mar; 86(3):558-66. PubMed ID: 9066321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are plasma concentration values necessary for pharmacodynamic modeling of muscle relaxants?
    Fisher DM; Wright PM
    Anesthesiology; 1997 Mar; 86(3):567-75. PubMed ID: 9066322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide.
    Szenohradszky J; Caldwell JE; Wright PM; Brown R; Lau M; Luks AM; Fisher DM
    Anesthesiology; 1999 Jan; 90(1):24-35. PubMed ID: 9915309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium.
    Proost JH; Wright PM
    Eur J Anaesthesiol Suppl; 2001; 23():83-9. PubMed ID: 11766253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ORG 9487 neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans.
    Debaene B; Lieutaud T; Billard V; Meistelman C
    Anesthesiology; 1997 Jun; 86(6):1300-5; discussion 7A. PubMed ID: 9197299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans.
    Wright PM; Caldwell JE; Miller RD
    Anesthesiology; 1994 Nov; 81(5):1110-5. PubMed ID: 7978469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response and onset/offset characteristics of rapacuronium.
    Kopman AF; Klewicka MM; Ghori K; Flores F; Neuman GG
    Anesthesiology; 2000 Oct; 93(4):1017-21. PubMed ID: 11020757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
    Wight WJ; Wright PM
    Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of twitch depression of the adductor pollicis and the respiratory muscles. Pharmacodynamic modeling without plasma concentrations.
    Bragg P; Fisher DM; Shi J; Donati F; Meistelman C; Lau M; Sheiner LB
    Anesthesiology; 1994 Feb; 80(2):310-9. PubMed ID: 7906111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular effects of rapacuronium on the diaphragm and skeletal muscles in anaesthetized patients using cervical magnetic stimulation for stimulating the phrenic nerves.
    Moerer O; Baller C; Hinz J; Buscher H; Crozier TA
    Eur J Anaesthesiol; 2002 Dec; 19(12):883-7. PubMed ID: 12510907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488).
    Schiere S; Proost JH; Schuringa M; Wierda JM
    Anesth Analg; 1999 Mar; 88(3):640-7. PubMed ID: 10072020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 2000 Feb; 92(2):376-86. PubMed ID: 10691223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion.
    Fisher DM; Dempsey GA; Atherton DP; Brown R; Abengochea A; Hunter JM
    Anesthesiology; 2000 Dec; 93(6):1384-91. PubMed ID: 11149430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early reversal of rapacuronium with neostigmine.
    Purdy R; Bevan DR; Donati F; Lichtor JL
    Anesthesiology; 1999 Jul; 91(1):51-7. PubMed ID: 10422928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisatracurium neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans.
    Kim KS; Chung CW; Shin WJ
    Br J Anaesth; 1999 Sep; 83(3):483-4. PubMed ID: 10655927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis.
    Donati F; Meistelman C; Plaud B
    Anesthesiology; 1991 May; 74(5):833-7. PubMed ID: 1673592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular rapacuronium in infants and children: dose-ranging and tracheal intubating conditions.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 1999 Nov; 91(5):1285-92. PubMed ID: 10551578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.